Holen Sie sich die Stockscreener-App
100.95
0.01%
0.01
Handel nachbörslich:
100.95
Schlusskurs vom Vortag:
$100.94
Offen:
$100.95
24-Stunden-Volumen:
1.30M
Relative Volume:
1.02
Marktkapitalisierung:
$6.59B
Einnahmen:
$1.54B
Nettoeinkommen (Verlust:
$233.56M
KGV:
29.98
EPS:
3.3669
Netto-Cashflow:
$348.64M
1W Leistung:
+0.00%
1M Leistung:
-1.39%
6M Leistung:
+45.50%
1J Leistung:
+85.33%
1-Tages-Spanne:
$100.85
$101.10
1-Wochen-Bereich:
$100.58
$101.10
52-Wochen-Spanne:
$49.67
$111.86
Lantheus Holdings Inc Stock (LNTH) Company Profile
Firmenname
Lantheus Holdings Inc
Sektor
Telefon
978 671-8001
Adresse
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
100.95 | 6.57B | 1.54B | 233.56M | 348.64M | 3.3669 |
TAK
Takeda Pharmaceutical Co Adr
|
17.63 | 55.60B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.77 | 42.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.70 | 43.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.79 | 30.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
499.73 | 21.95B | 3.17B | 1.29B | 1.01B | 27.09 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-12-12 | Hochstufung | Truist | Hold → Buy |
| 2025-10-08 | Herabstufung | Goldman | Buy → Neutral |
| 2025-08-12 | Herabstufung | Truist | Buy → Hold |
| 2024-12-18 | Eingeleitet | Goldman | Buy |
| 2024-09-03 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-07-10 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-12-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Eingeleitet | TD Cowen | Outperform |
| 2023-09-29 | Eingeleitet | William Blair | Outperform |
| 2023-03-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-11-30 | Eingeleitet | SVB Leerink | Outperform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-05-09 | Eingeleitet | B. Riley Securities | Buy |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2021-02-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-29 | Fortgesetzt | Jefferies | Buy |
| 2019-08-16 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-09-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2016-02-24 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-12-11 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Eingeleitet | Credit Suisse | Outperform |
| 2015-07-20 | Eingeleitet | Jefferies | Buy |
| 2015-07-20 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-07-20 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-20 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten
FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics - Sahm
Weekly Buzz: LNTH, CBLL Win FDA Nod; AURA Cuts Jobs; TDY Buys VREX; CGEM, DFTX Meet Trial Goals - RTTNews
US FDA approves Lantheus’ brain-imaging agent for Alzheimer’s assessment - KWSN
LNTH Looks 10.1% Overvalued on GF Value™ - GuruFocus
US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment - Reuters
Lantheus Wins FDA Approval for Alzheimer's Tau Imaging Agent Tauklarify - marketscreener.com
Lantheus tau PET imaging agent approved for Alzheimer’s (LNTH) - Seeking Alpha
FDA approves Lantheus’ tau imaging agent for Alzheimer’s disease - Investing.com
FDA approves Lantheus’ tau imaging agent for Alzheimer’s disease By Investing.com - Investing.com Australia
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease - The Manila Times
FDA approves Lantheus brain scan to identify tau in Alzheimer’s - Stock Titan
Farallon group (LNTH) discloses 5.58M-share, 8.6% position in Lantheus - Stock Titan
Lantheus Holdings, Inc. (LNTH) Stock Forecasts - Yahoo Finance
Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives Consensus Rating of "Hold" from Analysts - marketbeat.com
(LNTH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Bowman Consulting Group Ltd. (Nasdaq – BWMN), Bowhead Specialty Holdings Inc. (NYSE – BOW), Lantheus Holdings Inc. (Nasdaq – LNTH), Safety Insuran - WBOC TV
Pacer Advisors Inc. Reduces Stock Holdings in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus Holdings: Why I Am Exiting Before The Merger Closes (NASDAQ:LNTH) - Seeking Alpha
Lantheus Holdings (LNTH): Investor Outlook on Strong Upside Potential and Robust Product Portfolio - DirectorsTalk Interviews
Empowered Funds LLC Takes Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus Holdings, Inc. $LNTH is Reinhart Partners LLC.'s 2nd Largest Position - marketbeat.com
Assenagon Asset Management S.A. Raises Stock Holdings in Lantheus Holdings, Inc. $LNTH - marketbeat.com
Lantheus (LNTH) Stock Shrugs Off Solid Profit As Margin Questions Linger - Sahm
Lantheus (NASDAQ:LNTH) Releases Earnings Results, Beats Expectations By $0.25 EPS - MarketBeat
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc.LNTH - Business Wire
Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders? - Sahm
Form 8K Lantheus Holdings Inc For: 6 August By Investing.com - Investing.com South Africa
LNTH Looks 12.1% Overvalued on GF Value™ - GuruFocus
Lantheus Holdings, Inc. Suspends its Previously Issued Full Year 2026 Financial Guidance - marketscreener.com
Lantheus Holdings Inc earnings beat by $0.26, revenue topped estimates - Investing.com
Lantheus' Q2 Adjusted Earnings Fall, Revenue Rises - marketscreener.com
Lantheus Holdings, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Is Lantheus Holdings Inc (LNTH) Overvalued Despite Q2 Earnings M - GuruFocus
LNTH: Q2 2026 saw revenue growth, strategic acquisitions, and a pending merger with Curium - TradingView
Earnings Flash (LNTH) Lantheus Holdings, Inc. Reports Q2 Revenue $388.2M, vs. FactSet Est of $363.2M - marketscreener.com
Earnings Flash (LNTH) Lantheus Holdings, Inc. Posts Q2 Adjusted EPS $1.55 per Share, vs. FactSet Est of $1.30 - marketscreener.com
Lantheus Q2 revenue rises to $388.2 million - Quiver Quantitative
Lantheus Holdings: Q2 Earnings Snapshot - Barchart.com
Lantheus (NASDAQ:LNTH) Reports Upbeat Q2 CY2026 - Yahoo Finance
Lantheus Reports Second Quarter 2026 Financial Results - marketscreener.com
Press Release: Lantheus Reports Second Quarter 2026 Financial Results - Moomoo
California State Teachers Retirement System Raises Stock Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus earnings in focus as investors weigh Curium merger deal By Investing.com - Investing.com
First Trust Advisors LP Purchases 44,713 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
Earnings To Watch: Lantheus (LNTH) Reports Q2 Results Tomorrow - Barchart.com
54-Billion-Yuan Deal Officially Unveiled: Creating the Largest Merger & Acquisition in Radiopharmaceutical Sector History - 36Kr
France: Curium to merge with Lantheus in mega US$8bn radiopharmaceutical transaction - Investors in Healthcare
Lantheus to Be Acquired by Curium for $102.50 Cash Plus Up to $12.00 CVR - TradingView
Curium to acquire Lantheus in all-cash deal worth up to $8bn - Yahoo Finance
Lantheus (LNTH) Agrees To Join Curium In Radiopharmaceuticals Deal - Yahoo Finance
Lantheus Holdings, Inc. Stock 12‑Month Price Target Cut to $110.17, Implies 11% Upside - TradingView
Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
5.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):